JP2017511876A5 - - Google Patents

Download PDF

Info

Publication number
JP2017511876A5
JP2017511876A5 JP2016548691A JP2016548691A JP2017511876A5 JP 2017511876 A5 JP2017511876 A5 JP 2017511876A5 JP 2016548691 A JP2016548691 A JP 2016548691A JP 2016548691 A JP2016548691 A JP 2016548691A JP 2017511876 A5 JP2017511876 A5 JP 2017511876A5
Authority
JP
Japan
Prior art keywords
population
cd49a
msc
differentiated
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016548691A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017511876A (ja
JP6628253B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2015/050159 external-priority patent/WO2015121859A1/en
Publication of JP2017511876A publication Critical patent/JP2017511876A/ja
Publication of JP2017511876A5 publication Critical patent/JP2017511876A5/ja
Application granted granted Critical
Publication of JP6628253B2 publication Critical patent/JP6628253B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016548691A 2014-02-11 2015-02-11 細胞の適性を判定する方法 Active JP6628253B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461938172P 2014-02-11 2014-02-11
US61/938,172 2014-02-11
PCT/IL2015/050159 WO2015121859A1 (en) 2014-02-11 2015-02-11 Method of qualifying cells

Publications (3)

Publication Number Publication Date
JP2017511876A JP2017511876A (ja) 2017-04-27
JP2017511876A5 true JP2017511876A5 (enExample) 2018-01-11
JP6628253B2 JP6628253B2 (ja) 2020-01-08

Family

ID=52682791

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016548691A Active JP6628253B2 (ja) 2014-02-11 2015-02-11 細胞の適性を判定する方法

Country Status (7)

Country Link
US (1) US10564149B2 (enExample)
EP (1) EP3105587B1 (enExample)
JP (1) JP6628253B2 (enExample)
BR (1) BR112016018489A2 (enExample)
CA (1) CA2937305C (enExample)
IL (1) IL246943B (enExample)
WO (1) WO2015121859A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2880151B1 (en) 2012-08-06 2020-06-03 Brainstorm Cell Therapeutics Ltd. Methods of generating mesenchymal stem cells which secrete neurotrophic factors
EP3105587B1 (en) 2014-02-11 2023-09-06 Brainstorm Cell Therapeutics Ltd. Method of qualifying cells
JP6998768B2 (ja) 2015-08-28 2022-02-10 ロート製薬株式会社 Ror1陽性の間葉系幹細胞及びその調製方法、ror1陽性の間葉系幹細胞を含む医薬組成物及びその調製方法、並びにror1陽性の間葉系幹細胞を用いる疾患の予防又は治療方法
JP6153653B2 (ja) * 2015-12-07 2017-06-28 株式会社Cells Power 幹細胞培養方法
EP3429360A4 (en) * 2016-03-16 2019-08-28 Cell Medicine, Inc. MESENCHYMAL STEM CELLS WITH IMPROVED EFFICACY
AU2017301035A1 (en) 2016-07-18 2019-02-07 Brainstorm Cell Therapeutics Ltd Methods for treating amyotrophic lateral sclerosis (ALS)
CN108559729B (zh) * 2018-02-05 2022-01-14 上海科技大学 Fam49基因及其编码蛋白的应用
WO2019198077A1 (en) 2018-04-10 2019-10-17 Brainstorm Cell Therapeutics Ltd. Cell-type specific exosomes and use thereof
EP3850108A4 (en) * 2018-10-18 2022-08-03 Quadrant Biosciences Inc. MOLECULAR AND FUNCTIONAL CHARACTERIZATION OF EARLY-STAGE PARKINSON'S DISEASE AND TREATMENTS
WO2020086667A1 (en) * 2018-10-25 2020-04-30 American University Method for promoting adipocyte differentiation and obesity-related disease treatment
CN111979186B (zh) * 2020-08-21 2022-04-08 遵义医科大学附属医院 一种快速高效体外扩增人间充质干细胞的方法及应用
US20250075184A1 (en) * 2021-03-30 2025-03-06 Kaneka Corporation Method for inhibiting trypsin, and method for producing a cell preparation using the same
US12702730B2 (en) * 2021-04-30 2026-08-11 Stemcellago Inc. Engineered cartilage

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
JP3948971B2 (ja) 2001-08-30 2007-07-25 サンバイオ,インコーポレイティド Notch遺伝子の導入を用いて骨髄間質細胞を神経細胞及び骨格筋細胞に分化・誘導する方法
CA2475288C (en) 2002-02-06 2014-09-02 Sanbio, Inc. Method of inducing differentiation of bone marrow stromal cells to neural cells or skeletal muscle cells by introduction of notch gene
IL152905A0 (en) 2002-11-17 2003-06-24 Univ Ramot Dopaminergic markers induction in neuronal-like cells isolated from adult human bone marrow stromal cells: implications for novel gene therapy strategy for parkinsons disease
EP2465924A3 (en) 2005-06-16 2013-01-02 Ramot at Tel-Aviv University Ltd. Isolated cells and populations comprising same for the treament of cns diseases
WO2007066338A1 (en) 2005-12-08 2007-06-14 Ramot At Tel Aviv University Ltd. Isolated oligodendrocyte-like cells and populations comprising same for the treatment of cns diseases
ES2729557T3 (es) * 2008-05-28 2019-11-04 Univ Ramot Células madre mesenquimatosas para el tratamiento de enfermedades del SNC
US20100184033A1 (en) 2008-07-16 2010-07-22 West Michael D Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby
GB0814249D0 (en) * 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
IL281453B (en) * 2009-11-17 2022-07-01 Astellas Inst For Regenerative Medicine Methods for preparing human rpe cells and pharmaceutical preparations of human rpe cells
ES2600321T3 (es) * 2011-08-04 2017-02-08 Ethianum Betriebsgesellschaft Mbh & Co. Kg Medios para la regeneración del hígado
DE102011121982B3 (de) * 2011-12-22 2013-04-18 Dietmar Hopp Stiftung GmbH Mesenchymale Stammzellen aus Fettgewebe (ADSC) zur Rekonstruktion von Haut und Weichteilgewebe
CN104471059B (zh) * 2012-07-12 2018-04-17 珠海横琴爱姆斯坦生物科技有限公司 人胚胎干细胞衍生的间充质样干细胞、方法及其应用
EP2880151B1 (en) 2012-08-06 2020-06-03 Brainstorm Cell Therapeutics Ltd. Methods of generating mesenchymal stem cells which secrete neurotrophic factors
EP3105587B1 (en) 2014-02-11 2023-09-06 Brainstorm Cell Therapeutics Ltd. Method of qualifying cells

Similar Documents

Publication Publication Date Title
Madeira et al. Nonviral gene delivery to mesenchymal stem cells using cationic liposomes for gene and cell therapy
Zhu et al. Generation of three-dimensional meat-like tissue from stable pig epiblast stem cells
Gu et al. Changes in mesenchymal stem cells following long-term culture in vitro
Alcayaga-Miranda et al. Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells
Li et al. Low levels of TGF-β1 enhance human umbilical cord-derived mesenchymal stem cell fibronectin production and extend survival time in a rat model of lipopolysaccharide-induced acute lung injury
AU2015297347B2 (en) Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method
Khanjani et al. Efficient generation of functional hepatocyte‐like cells from menstrual blood‐derived stem cells
Ylöstalo et al. Reversible commitment to differentiation by human multipotent stromal cells in single-cell–derived colonies
Patel et al. Novel isolation strategy to deliver pure fetal-origin and maternal-origin mesenchymal stem cell (MSC) populations from human term placenta
Seong et al. mRNA and miRNA profiling of Zika virus-infected human umbilical cord mesenchymal stem cells identifies miR-142-5p as an antiviral factor
WO2015121859A8 (en) Method of qualifying cells
US10935542B2 (en) Method for identification and culture of multipotent mesenchymal stem cells with high proliferation potential
HRP20201487T1 (hr) Stvaranje banke stanica strome mezenhima iz mononuklearnih stanica prikupljenih iz više donora koštane srži
Pode-Shakked et al. Evidence of in vitro preservation of human nephrogenesis at the single-cell level
Ruedel et al. Development of a model system to analyze chondrogenic differentiation of mesenchymal stem cells
JP6463029B2 (ja) ヒト間葉系幹細胞を特異的に認識するモノクローナル抗体並びにこれを用いたヒト間葉系幹細胞の分離及び/または品質評価を行う方法
RU2017139097A (ru) Способ оценки и/или мониторинга in vitro чистоты препарата клеток, применение фактора роста, популяции клеток, набор
Batista Telomere biology in stem cells and reprogramming
Galkowski et al. Of cytometry, stem cells and fountain of youth
Silva Filho et al. Isolation and characterization of mesenchymal progenitors derived from the bone marrow of goats native from northeastern Brazil
Zdyrski et al. Establishment and transcriptomic characterization of canine organoids from multiple tissues
KR102142254B1 (ko) 3,4''-다이하이드록시플라본을 이용한 소변줄기세포의 분리 효율 향상 및 소변줄기세포유래 만능줄기세포의 조혈줄기세포 분화 효율을 촉진시키는 방법
JP2014163749A5 (enExample)
Xu et al. Co-culture of annulus fibrosus cells and bone marrow mesenchymal stem cells.
Li et al. The CCL7-CCL2-CCR2 Axis Regulates Age-Related Alterations in ADSCs